Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blinded, Parallel, Vehicle-Controlled Phase 2 Study of SHJ002 Sterile Ophthalmic Solution in Participants With Dry Eye Disease

NCT05486728 is registered in ClinicalTrials.gov with Dreamhawk Vision Biotech, Inc. as lead sponsor.

NCT NCT05486728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05486728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blinded, Parallel, Vehicle-Controlled Phase 2 Study of SHJ002 Sterile Ophthalmic Solution in Participants With Dry Eye Disease
Lead sponsor
Dreamhawk Vision Biotech, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 8, 2023
Completion date
December 7, 2023
Enrollment
85 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease